Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas
Tóm tắt
Từ khóa
Tài liệu tham khảo
Steg, 2007, Oneyear cardiovascular event rates in outpatients with atherothrombosis, JAMA, 297, 1197, 10.1001/jama.297.11.1197
Criqui, 1992, Mortality over a period of 10 years in patients with peripheral arterial disease, N Engl J Med, 326, 381, 10.1056/NEJM199202063260605
Sigvant, 2007, A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences, J Vasc Surg, 45, 1185, 10.1016/j.jvs.2007.02.004
Kroger, 2006, Prevalence of peripheral arterial disease —results of the Heinz Nixdorf recall study, Eur J Epidemiol, 21, 279, 10.1007/s10654-006-0015-9
Kannel, 1985, Update on some epidemiologic features of intermittent claudication: the Framingham Study, J Am Geriatr Soc, 33, 13, 10.1111/j.1532-5415.1985.tb02853.x
Norgren, 2007, Inter- Society Consensus for the Management of Peripheral Arterial Disease (TASC II), J Vasc Surg, 45, S5, 10.1016/j.jvs.2006.12.037
Ingolfsson, 1994, A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol—the Reykjavik Study, J Clin Epidemiol, 47, 1237, 10.1016/0895-4356(94)90128-7
Murabito, 2005, Temporal trends in the incidence of intermittent claudication from 1950 to 1999, Am J Epidemiol, 162, 430, 10.1093/aje/kwi217
Bots, 1992, Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study, Hypertension, 19, 717, 10.1161/01.HYP.19.6.717
Mathiesen, 2001, Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study, Cerebrovasc Dis, 12, 44, 10.1159/000047680
O, 1992, Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study, The CHS Collaborative Research Group, Stroke, 23, 1752
Hansen, 2002, Prevalence of renovascular disease in the elderly: a population-based study, J Vasc Surg, 36, 443, 10.1067/mva.2002.127351
De Mast, 2009, The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review, J Hypertens, 27, 1333, 10.1097/HJH.0b013e328329bbf4
Valentine, 1991, Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses, J Vasc Surg, 14, 195, 10.1067/mva.1991.29423
Shadman, 2004, Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases, J Am Coll Cardiol, 44, 618, 10.1016/j.jacc.2004.04.044
Fowkes, 1992, Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study, Am J Epidemiol, 135, 331, 10.1093/oxfordjournals.aje.a116294
Criqui, 2001, Peripheral arterial disease —epidemiological aspects, Vasc Med, 6, 3, 10.1177/1358836X0100600i102
Stoffers, 1996, The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease, Int J Epidemiol, 25, 282, 10.1093/ije/25.2.282
Meijer, 1998, Peripheral arterial disease in the elderly: the Rotterdam Study, Arterioscler Thromb Vasc Biol, 18, 185, 10.1161/01.ATV.18.2.185
Ridker, 2001, Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease, JAMA, 285, 2481, 10.1001/jama.285.19.2481
Chrysochou, 2009, Epidemiology and natural history of atherosclerotic renovascular disease, Prog Cardiovasc Dis, 52, 184, 10.1016/j.pcad.2009.09.001
English, 2001, Angiographic prevalence and clinical predictors of left subclavian stenosis in patients undergoing diagnostic cardiac catheterization, Catheter Cardiovasc Interv, 54, 8, 10.1002/ccd.1230
Pickett, 2008, Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis, Lancet, 371, 1587, 10.1016/S0140-6736(08)60691-1
Reiner, 2011, ESC/EAS Guidelines for the managemeint of dyslipidaemias, Eur Heart J, 32, 1769
Fowkes, 2010, Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial, JAMA, 303, 841, 10.1001/jama.2010.221
Criqui, 2010, The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 56, 1506, 10.1016/j.jacc.2010.04.060
Ruehm, 2001, Rapid magnetic resonance angiography for detection of atherosclerosis, Lancet, 357, 1086, 10.1016/S0140-6736(00)04261-6
Goyen, 2002, Wholebody three-dimensional MR angiography with a rolling table platform: initial clinical experience, Radiology, 224, 270, 10.1148/radiol.2241011345
Gohde, 2002, Prevention without radiation— a strategy for comprehensive early detection using magnetic resonance tomography], Radiologe, 42, 622
Fenchel, 2006, Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results, Radiology, 238, 280, 10.1148/radiol.2381041532
Fowler, 2002, Prevalence of peripheral arterial disease: persistence of excess risk in former smokers, Aust N Z J Public Health, 26, 219, 10.1111/j.1467-842X.2002.tb00677.x
Smith, 1998, Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication, J Vasc Surg, 28, 129, 10.1016/S0741-5214(98)70208-3
Steinberg, 2009, Triple-combination pharmacotherapy for medically ill smokers: a randomized trial, Ann Intern Med, 150, 447, 10.7326/0003-4819-150-7-200904070-00004
Aboyans, 2010, The cardiologist and smoking cessation, Curr Opin Cardiol, 25, 469, 10.1097/HCO.0b013e32833cd4f7
Collins, 2003, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial, Lancet, 361, 2005, 10.1016/S0140-6736(03)13636-7
Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348:1329-39.
Bhatt, 2006, CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989
Cacoub, 2009, Patients with peripheral arterial disease in the CHARISMA trial, Eur Heart J, 30, 192, 10.1093/eurheartj/ehn534
Mancia, 2007, Eur Heart J, 28, 1462
Mancia, 2009, European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, J Hypertens, 27, 2121, 10.1097/HJH.0b013e328333146d
Yusuf, 2000, Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301
Yusuf, 2008, Telmisartan, ramipril, or both in patients at high risk for vascular events, N Engl J Med, 358, 1547, 10.1056/NEJMoa0801317
Radack, 1991, Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials, Arch Intern Med, 151, 1769, 10.1001/archinte.1991.00400090063012
Aronow, 2001, Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease, Am J Cardiol, 87, 1284, 10.1016/S0002-9149(01)01521-1
Hobbs, 2003, Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach, Eur J Vasc Endovasc Surg, 26, 341, 10.1016/S1078-5884(03)00356-3
Grau, 2001, Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank, Stroke, 32, 2559, 10.1161/hs1101.098524
Barnett, 1998, Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators, N Engl J Med, 339, 1415, 10.1056/NEJM199811123392002
European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351:1379-87.
Inzitari, 2000, The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators, N Engl J Med, 342, 1693, 10.1056/NEJM200006083422302
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273:1421-8.
Halliday, 2004, Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial, Lancet, 363, 1491, 10.1016/S0140-6736(04)16146-1
Abbott, 2009, Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis, Stroke, 40, e573, 10.1161/STROKEAHA.109.556068
Schneider, 2010, Transatlantic debate. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting, Eur J Vasc Endovasc Surg, 40, 274, 10.1016/j.ejvs.2010.05.004
Rothwell, 2005, A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack, Lancet, 366, 29, 10.1016/S0140-6736(05)66702-5
Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003; 229:340-6.
Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess. 2006; 10:iii-iv, ix-x, 1-182.
Amarenco, 2006, High-dose atorvastatin after stroke or transient ischemic attack, N Engl J Med, 355, 549, 10.1056/NEJMoa061894
Sillesen, 2008, Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, Stroke, 39, 3297, 10.1161/STROKEAHA.108.516450
Bond, 2004, Patch angioplasty versus primary closure for carotid endarterectomy, Cochrane Database Syst Rev, CD000160
Mannheim, 2005, Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study, J Vasc Surg, 41, 403, 10.1016/j.jvs.2004.11.036
Cao, 2001, Eversion versus conventional carotid endarterectomy for preventing stroke, Cochrane Database Syst Rev, CD001921
Lewis, 2008, General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial, Lancet, 372, 2132, 10.1016/S0140-6736(08)61699-2
Halliday, 2010, 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial, Lancet, 376, 1074, 10.1016/S0140-6736(10)61197-X
McKevitt, 2005, The benefits of combined anti-platelet treatment in carotid artery stenting, Eur J Vasc Endovasc Surg, 29, 522, 10.1016/j.ejvs.2005.01.012
Dalainas, 2006, Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting, Cardiovasc Intervent Radiol, 29, 519, 10.1007/s00270-005-5288-y
Roffi, 2010, Carotid artery stenting versus surgery: adequate comparisons?, Lancet Neurol, 9, 339, 10.1016/S1474-4422(10)70027-2
Barbato, 2008, A randomized trial of carotid artery stenting with and without cerebral protection, J Vasc Surg, 47, 760, 10.1016/j.jvs.2007.11.058
Macdonald, 2010, Filter-protected versus unprotected carotid artery stenting: a randomised trial, Cerebrovasc Dis, 29, 282, 10.1159/000275505
Kastrup, 2006, Incidence of new brain lesions after carotid stenting with and without cerebral protection, Stroke, 37, 2312, 10.1161/01.STR.0000236492.86303.85
Garg, 2009, Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature, J Endovasc Ther, 16, 412, 10.1583/09-2713.1
Zahn, 2004, Embolic protection devices for carotid artery stenting: better results than stenting without protection?, Eur Heart J, 25, 1550, 10.1016/j.ehj.2004.06.018
Cremonesi, 2003, Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients, Stroke, 34, 1936, 10.1161/01.STR.0000081000.23561.61
Jansen, 2009, Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial, Stroke, 40, 841, 10.1161/STROKEAHA.108.534289
Bonati, 2010, New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS), Lancet Neurol, 9, 353, 10.1016/S1474-4422(10)70057-0
Massop, 2009, Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients, Catheter Cardiovasc Interv, 73, 129, 10.1002/ccd.21844
Brott, 2010, Stenting versus endarterectomy for treatment of carotid-artery stenosis, N Engl J Med, 363, 11, 10.1056/NEJMoa0912321
Stabile, 2010, Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients, J Am Coll Cardiol, 55, 1661, 10.1016/j.jacc.2009.11.079
Hobson RW 2nd, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328:221-7.
Roffi, 2009, Carotid artery stenting vs. endarterectomy, Eur Heart J, 30, 2693, 10.1093/eurheartj/ehp471
Gray, 2007, The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting, Catheter Cardiovasc Interv, 69, 341, 10.1002/ccd.21050
Katzen, 2007, Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study, Catheter Cardiovasc Interv, 70, 316, 10.1002/ccd.21222
Theiss, 2004, Pro- CAS: a prospective registry of carotid angioplasty and stenting, Stroke, 35, 2134, 10.1161/01.STR.0000135763.62131.6a
Sidawy, 2009, Riskadjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry, J Vasc Surg, 49, 71, 10.1016/j.jvs.2008.08.039
GrayWA, 2009, Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries, Circ Cardiovasc Interv, 2, 159, 10.1161/CIRCINTERVENTIONS.108.823013
Rothwell, 2007, Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison, Lancet, 370, 1432, 10.1016/S0140-6736(07)61448-2
Luengo-Fernandez, 2009, Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison, Lancet Neurol, 8, 235, 10.1016/S1474-4422(09)70019-5
Naylor, 2009, The importance of initiating ‘best medical therapy’ and intervening as soon as possible in patients with symptomatic carotid artery disease: time for a radical rethink of practice, J Cardiovasc Surg (Torino), 50, 773
Mayberg, 1991, Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group, JAMA, 266, 3289, 10.1001/jama.1991.03470230047029
Rothwell, 2003, Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis, Lancet, 361, 107, 10.1016/S0140-6736(03)12228-3
Rothwell, 2004, Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery, Lancet, 363, 915, 10.1016/S0140-6736(04)15785-1
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001; 357:1729-37.
Mas, 2006, Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis, N Engl J Med, 355, 1660, 10.1056/NEJMoa061752
Ederle, 2010, Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial, Lancet, 375, 985, 10.1016/S0140-6736(10)60239-5
Fiehler, 2008, Differences in complication rates among the centres in the SPACE study, Neuroradiology, 50, 1049, 10.1007/s00234-008-0459-6
Yadav, 2004, Protected carotid-artery stenting versus endarterectomy in high-risk patients, N Engl J Med, 351, 1493, 10.1056/NEJMoa040127
Gurm, 2008, Long-term results of carotid stenting versus endarterectomy in high-risk patients, N Engl J Med, 358, 1572, 10.1056/NEJMoa0708028
Ederle, 2009, Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial, Lancet Neurol, 8, 898, 10.1016/S1474-4422(09)70228-5
Ringleb, 2006, 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial, Lancet, 368, 1239, 10.1016/S0140-6736(06)69122-8
Eckstein, 2008, Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial, Lancet Neurol, 7, 893, 10.1016/S1474-4422(08)70196-0
Mas, 2004, Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial, Stroke, 35, e18
Mas, 2008, Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial, Lancet Neurol, 7, 885, 10.1016/S1474-4422(08)70195-9
Economopoulos, 2011, Carotid artery stenting versus carotid endarterectomy: a comprehensive metaanalysis of short-term and long-term outcomes, Stroke, 42, 687, 10.1161/STROKEAHA.110.606079
Marquardt, 2009, Incidence and prognosis of ≥50% symptomatic vertebral or basilar artery stenosis: prospective population-based study, Brain, 132, 982, 10.1093/brain/awp026
Bogousslavsky, 1988, The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke, Stroke, 19, 1083, 10.1161/01.STR.19.9.1083
Bogousslavsky, 1986, Borderzone infarctions distal to internal carotid artery occlusion: prognostic implications, Ann Neurol, 20, 346, 10.1002/ana.410200312
Wityk, 1998, Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry, Arch Neurol, 55, 470, 10.1001/archneur.55.4.470
Caplan, 2004, New England Medical Center Posterior Circulation registry, Ann Neurol, 56, 389, 10.1002/ana.20204
Khan, 2007, Imaging of vertebral artery stenosis: a systematic review, J Neurol Neurosurg Psychiatry, 78, 1218, 10.1136/jnnp.2006.111716
Berguer, 2000, Surgical reconstruction of the extracranial vertebral artery: management and outcome, J Vasc Surg, 31, 9, 10.1016/S0741-5214(00)70063-2
Aboyans, 2007, The vital prognosis of subclavian stenosis, J Am Coll Cardiol, 49, 1540, 10.1016/j.jacc.2006.09.055
Sixt, 2009, Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction, Catheter Cardiovasc Interv, 73, 395, 10.1002/ccd.21836
De Vries, 2005, Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results, J Vasc Surg, 41, 19, 10.1016/j.jvs.2004.09.030
Cina, 2002, Subclavian carotid transposition and bypass grafting: consecutive cohort study and systematic review, J Vasc Surg, 35, 422, 10.1067/mva.2002.120035
Hughes, 2007, Bypass for chronic ischemia of the upper extremity: results in 20 patients, J Vasc Surg, 46, 303, 10.1016/j.jvs.2007.04.035
Bakken, 2008, Outcomes of endoluminal therapy for ostial disease of the major branches of the aortic arch, Ann Vasc Surg, 22, 388, 10.1016/j.avsg.2007.07.040
Lee, 2006, A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia, World J Surg, 30, 1644, 10.1007/s00268-005-0559-y
Thomas, 1998, The clinical course of asymptomatic mesenteric arterial stenosis, J Vasc Surg, 27, 840, 10.1016/S0741-5214(98)70263-0
Van Bockel, 2001, Chronic splanchnic ischaemia, Best Pract Res Clin Gastroenterol, 15, 99, 10.1053/bega.2001.0158
Babu, 1993, Celiac territory ischemic syndrome in visceral artery occlusion, Am J Surg, 166, 227, 10.1016/S0002-9610(05)81061-X
Liberski, 1990, Ischemic gastroparesis: resolution after revascularization, Gastroenterology, 99, 252, 10.1016/0016-5085(90)91255-5
Ghosh, 2002, Risk factors for intestinal ischaemia in cardiac surgical patients, Eur J Cardiothorac Surg, 21, 411, 10.1016/S1010-7940(02)00015-5
Wilson, 2006, Clinical course of mesenteric artery stenosis in elderly Americans, Arch Intern Med, 166, 2095, 10.1001/archinte.166.19.2095
Mensink, 2006, Clinical significance of splanchnic artery stenosis, Br J Surg, 93, 1377, 10.1002/bjs.5481
Moawad, 1997, Chronic mesenteric ischemia. Clinical presentation and diagnosis, Surg Clin North Am, 77, 357, 10.1016/S0039-6109(05)70554-5
Pellerito, 2009, Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis, J Ultrasound Med, 28, 641, 10.7863/jum.2009.28.5.641
Moneta, 1993, Mesenteric duplex scanning: a blinded prospective study, J Vasc Surg, 17, 79, 10.1016/0741-5214(93)90011-A
Armstrong, 2007, Visceral duplex scanning: evaluation before and after artery intervention for chronic mesenteric ischemia, Perspect Vasc Surg Endovasc Ther, 19, 386, 10.1177/1531003507311802
Dietrich, 2007, Sonographic assessment of splanchnic arteries and the bowel wall, Eur J Radiol, 64, 202, 10.1016/j.ejrad.2007.06.034
Zwolak, 1999, Can duplex ultrasound replace arteriography in screening for mesenteric ischemia?, Semin Vasc Surg, 12, 252
Cademartiri, 2008, Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia, Radiol Med, 113, 1135, 10.1007/s11547-008-0330-1
Horton, 2007, angiography in the diagnosis of mesenteric ischemia, Radiol Clin North Am, 45, 275, 10.1016/j.rcl.2007.03.010
Hellinger, 2004, Evaluating mesenteric ischemia with multidetector-row CT angiography, Tech Vasc Interv Radiol, 7, 160, 10.1053/j.tvir.2005.02.002
Laghi, 2001, Multislice spiral computed tomography angiography of mesenteric arteries, Lancet, 358, 638, 10.1016/S0140-6736(01)05786-5
Otte, 2008, Jejunal tonometry for the diagnosis of gastrointestinal ischemia. Feasibility, normal values and comparison of jejunal with gastric tonometry exercise testing, Eur J Gastroenterol Hepatol, 20, 62, 10.1097/MEG.0b013e3282ef633a
Cleveland, 2002, Mesenteric arterial ischaemia: diagnosis and therapeutic options, Vasc Med, 7, 311, 10.1191/1358863x02vm454ra
Cognet, 2002, Chronic mesenteric ischemia: imaging and percutaneous treatment, Radiographics, 22, 863, 10.1148/radiographics.22.4.g02jl07863
Laissy, 2002, MR angiography: noninvasive vascular imaging of the abdomen, Abdom Imaging, 27, 488, 10.1007/s00261-001-0063-2
Schermerhorn, 2009, Mesenteric revascularization: management and outcomes in the United States, 1988-2006, J Vasc Surg, 50, 341, 10.1016/j.jvs.2009.03.004
Davies, 2009, Surgical versus endovascular reconstruction for chronic mesenteric ischemia: a contemporary UK series, Vasc Endovascular Surg, 43, 157, 10.1177/1538574408328665
Lee, 2008, Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease, Ann Vasc Surg, 22, 541, 10.1016/j.avsg.2007.09.019
Zerbib, 2008, Endovascular versus open revascularization for chronic mesenteric ischemia: a comparative study, Langenbecks Arch Surg, 393, 865, 10.1007/s00423-008-0355-x
AbuRahma, 2003, Angioplasty/stenting of the superior mesenteric artery and celiac trunk: early and late outcomes, J Endovasc Ther, 10, 1046, 10.1177/152660280301000604
Zeller, 2007, Endovascular therapy of chronic mesenteric ischaemia, EuroIntervention, 2, 444
Schaefer, 2006, Stent placement with the monorail technique for treatment of mesenteric artery stenosis, J Vasc Interv Radiol, 17, 637, 10.1097/01.RVI.0000208983.39430.F9
Mell, 2008, Outcomes after endarterectomy for chronic mesenteric ischemia, J Vasc Surg, 48, 1132, 10.1016/j.jvs.2008.06.033
Biebl, 2007, Surgical and interventional visceral revascularization for the treatment of chronic mesenteric ischemia—when to prefer which?, World J Surg, 31, 562, 10.1007/s00268-006-0434-5
Safian, 2001, Med, 344, 431
Neymark, 2000, Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery, Radiology, 214, 755, 10.1148/radiology.214.3.r00mr18755
De Bruyne, 2006, Assessment of renal artery stenosis severity by pressure gradient measurements, J Am Coll Cardiol, 48, 1851, 10.1016/j.jacc.2006.05.074
Rimmer, 1993, Atherosclerotic renovascular disease and progressive renal failure, Ann Intern Med, 118, 712, 10.7326/0003-4819-118-9-199305010-00010
Caps, 1998, Risk of atrophy in kidneys with atherosclerotic renal artery stenosis, Kidney Int, 53, 735, 10.1046/j.1523-1755.1998.00805.x
Gloviczki, 2010, Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis, Hypertension, 55, 961, 10.1161/HYPERTENSIONAHA.109.145227
Fatica, 2001, Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States, Am J Kidney Dis, 37, 1184, 10.1053/ajkd.2001.24521
Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031
Hostetter, 2004, Chronic kidney disease predicts cardiovascular disease, N Engl J Med, 351, 1344, 10.1056/NEJMe048211
Levy, 1989, Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study, Ann Intern Med, 110, 101, 10.7326/0003-4819-110-2-101
Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203
Wright, 2005, Left ventricular morphology and function in patients with atherosclerotic renovascular disease, J Am Soc Nephrol, 16, 2746, 10.1681/ASN.2005010043
Greco, 1996, The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy?, Semin Nephrol, 16, 2
Schreiber, 1984, The natural history of atherosclerotic and fibrous renal artery disease, Urol Clin North Am, 11, 383, 10.1016/S0094-0143(21)00203-2
Zierler, 1996, A prospective study of disease progression in patients with atherosclerotic renal artery stenosis, Am J Hypertens, 9, 1055, 10.1016/0895-7061(96)00196-3
Jaarsveld van BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-14.
Connolly, 1994, Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease, QJM, 87, 413
Drieghe, 2008, Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements, Eur Heart J, 29, 517, 10.1093/eurheartj/ehm631
AIUM practice guideline for the performance of renal artery duplex sonography. J Ultrasound Med. 2009; 28:120-14.
Zeller, 2008, Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization, Catheter Cardiovasc Interv, 71, 995, 10.1002/ccd.21525
Zeller, 2001, [Color duplex ultrasound imaging of renal arteries and detection of hemodynamically relevant renal artery stenoses], Ultraschall Med, 22, 116, 10.1055/s-2001-15287
Radermacher, 2001, Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease, Curr Opin Nephrol Hypertens, 10, 799, 10.1097/00041552-200111000-00011
Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, et al. Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-82.
Kribben, 2009, Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy, J Am Coll Cardiol, 53, 1621, 10.1016/j.jacc.2008.12.061
Kapoor, 2010, Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements, Catheter Cardiovasc Interv, 76, 726, 10.1002/ccd.22731
Mangiacapra, 2010, Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension, Circ Cardiovasc Interv, 3, 537, 10.1161/CIRCINTERVENTIONS.110.957704
Jaarsveld van, 1997, The place of renal scintigraphy in the diagnosis of renal artery stenosis.Fifteen years of clinical experience, Arch Intern Med, 157, 1226, 10.1001/archinte.1997.00440320128012
Mailloux, 1994, Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience, Am J Kidney Dis, 24, 622, 10.1016/S0272-6386(12)80223-X
Zeller, 2003, Survival after stenting of severe atherosclerotic ostial renal artery stenoses, J Endovasc Ther, 10, 539, 10.1177/152660280301000320
Hackam, 2008, Angiotensin inhibition in renovascular disease: a population-based cohort study, Am Heart J, 156, 549, 10.1016/j.ahj.2008.05.013
Plouin, 2003, Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management, Am J Kidney Dis, 42, 851, 10.1016/j.ajkd.2003.08.006
Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Grou*p. J Hum Hypertens. 1998;12:329-35.
Nordmann, 2003, Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction, Cochrane Database Syst Rev, CD002944
Balk, 2006, Effectiveness of management strategies for renal artery stenosis: a systematic review, Ann Intern Med, 145, 901, 10.7326/0003-4819-145-12-200612190-00143
Gray, 2002, Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure, Vasc Med, 7, 275, 10.1191/1358863x02vm456oa
Kane, 2010, Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis, Nephrol Dial Transplant, 25, 813, 10.1093/ndt/gfp393
Kalra, 2010, Renal revascularization for heart failure in patients with atherosclerotic renovascular disease, Nephrol Dial Transplant, 25, 661, 10.1093/ndt/gfq026
Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-9.
Nordmann, 2003, Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis?. A metaanalysis of randomized controlled trials, Am J Med, 114, 44, 10.1016/S0002-9343(02)01396-7
Wheatley, 2009, Revascularization versus medical therapy for renal-artery stenosis, N Engl J Med, 361, 1953, 10.1056/NEJMoa0905368
Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009; 150:840-8, W150-W841.
Kalra, 2010, The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease, Catheter Cardiovasc Interv, 75, 1, 10.1002/ccd.22290
Krishnamurthi, 1999, Atheroembolic renal disease: effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis, J Urol, 161, 1093, 10.1016/S0022-5347(01)61598-2
Scolari, 2000, Cholesterol crystal embolism: a recognizable cause of renal disease, Am J Kidney Dis, 36, 1089, 10.1053/ajkd.2000.19809
Cooper, 2008, Embolic protection and platelet inhibition during renal artery stenting, Circulation, 117, 2752, 10.1161/CIRCULATIONAHA.107.730259
Bloch, 1999, Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement, Am J Hypertens, 12, 1, 10.1016/S0895-7061(98)00201-5
Symonides, 1999, Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology, Blood Press, 8, 141, 10.1080/080370599439661
Zeller, 2007, Regression of left ventricular hypertrophy following stenting of renal artery stenosis, J Endovasc Ther, 14, 189, 10.1177/152660280701400211
Schwarzwalder, 2009, RADAR—a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis, Trials, 10, 60, 10.1186/1745-6215-10-60
Sos, 1983, Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia, N Engl J Med, 309, 274, 10.1056/NEJM198308043090504
Davies, 2008, The longterm outcomes of percutaneous therapy for renal artery fibromuscular dysplasia, J Vasc Surg, 48, 865, 10.1016/j.jvs.2008.05.030
Trinquart, 2010, Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis, Hypertension, 56, 525, 10.1161/HYPERTENSIONAHA.110.152918
Van de Ven, 1999, Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial, Lancet, 353, 282, 10.1016/S0140-6736(98)04432-8
Rastan, 2008, Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION), EuroIntervention, 4, 208, 10.4244/EIJV4I2A38
Lederman, 2001, Primary renal artery stenting: characteristics and outcomes after 363 procedures, Am Heart J, 142, 314, 10.1067/mhj.2001.116958
Zahringer, 2007, Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years, J Endovasc Ther, 14, 460, 10.1177/152660280701400405
Misra, 2008, Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller, J Vasc Interv Radiol, 19, 833, 10.1016/j.jvir.2008.03.017
Zeller, 2007, Treatment of instent restenosis following stent-supported renal artery angioplasty, Catheter Cardiovasc Interv, 70, 454, 10.1002/ccd.21220
N’Dandu, 2008, Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone, Catheter Cardiovasc Interv, 71, 701, 10.1002/ccd.21509
Patel, 2009, Percutaneous revascularization of persistent renal artery in-stent restenosis, Vasc Med, 14, 259, 10.1177/1358863X08100386
Davies, 2009, Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting, J Vasc Surg, 49, 946, 10.1016/j.jvs.2008.11.039
Novick, 1987, Trends in surgical revascularization for renal artery disease. Ten years’ experience, JAMA, 257, 498, 10.1001/jama.1987.03390040114028
Clair, 1995, Safety and efficacy of transaortic renal endarterectomy as an adjunct to aortic surgery, J Vasc Surg, 21, 926, 10.1016/S0741-5214(95)70220-2
Cambria, 1994, The durability of different reconstructive techniques for atherosclerotic renal artery disease, J Vasc Surg, 20, 76, 10.1016/0741-5214(94)90178-3
Senekowitsch, 2004, Renal artery surgery in the era of endovascular intervention, Vasa, 33, 226, 10.1024/0301-1526.33.4.226
Balzer, 2009, Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD), J Vasc Surg, 49, 667, 10.1016/j.jvs.2008.10.006
Hollenberg, 1983, Medical therapy of renovascular hypertension: efficacy and safety of captopril in 269 patients, Cardiovasc Rev Rep, 4, 852
Dorros, 1993, Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty, Cathet Cardiovasc Diagn, 29, 191, 10.1002/ccd.1810290304
Zeller, 2004, Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions, J Endovasc Ther, 11, 95, 10.1583/03-1062.1
Zeller, 2003, Predictors of improved renal function after percutaneous stentsupported angioplasty of severe atherosclerotic ostial renal artery stenosis, Circulation, 108, 2244, 10.1161/01.CIR.0000095786.44712.2A
Korsakas, 2004, Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions, Kidney Int, 65, 251, 10.1111/j.1523-1755.2004.00353.x
Leng, 1992, The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys, J Clin Epidemiol, 45, 1101, 10.1016/0895-4356(92)90150-L
McDermott, 2001, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599
Lijmer, 1996, ROC analysis of noninvasive tests for peripheral arterial disease, Ultrasound Med Biol, 22, 391, 10.1016/0301-5629(96)00036-1
Stoffers, 1996, The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care, J Clin Epidemiol, 49, 1401, 10.1016/S0895-4356(96)00275-2
Baker, 1981, Variability of Doppler ankle pressures with arterial occlusive disease: an evaluation of ankle index and brachial-ankle pressure gradient, Surgery, 89, 134
Schroder, 2006, A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease, J Vasc Surg, 44, 531, 10.1016/j.jvs.2006.05.016
Stein, 2006, Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease, Vasc Med, 11, 29, 10.1191/1358863x06vm663oa
Aboyans, 2008, The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects, J Vasc Surg, 48, 1197, 10.1016/j.jvs.2008.06.005
Hiatt, 2005, Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials, Vasc Med, 10, 207, 10.1191/1358863x05vm628oa
Ouriel, 1982, Critical evaluation of stress testing in the diagnosis of peripheral vascular disease, Surgery, 91, 686
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31:S1-296.
Regensteiner, 1997, Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997, Vasc Med, 2, 147, 10.1177/1358863X9700200211
Koelemay, 1996, Diagnosis of arterial disease of the lower extremities with duplex ultrasonography, Br J Surg, 83, 404, 10.1002/bjs.1800830336
Visser, 2000, Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis, Radiology, 216, 67, 10.1148/radiology.216.1.r00jl0367
Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007; 11:iii-iv, xi-xiii, 1-184.
Winter-Warnars, 1996, Interobserver variation in duplex sonographic scanning in the femoropopliteal tract, J Ultrasound Med, 15, 421, 10.7863/jum.1996.15.6.421
Koelemay, 2001, Interobserver variation of colour duplex scanning of the popliteal, tibial and pedal arteries, Eur J Vasc Endovasc Surg, 21, 160, 10.1053/ejvs.2000.1306
Bandyk, 2007, Duplex ultrasound surveillance can be worthwhile after arterial intervention, Perspect Vasc Surg Endovasc Ther, 19, 354, 10.1177/1531003507311681
Ferris, 2003, Is early postoperative duplex scan surveillance of leg bypass grafts clinically important?, J Vasc Surg, 37, 495, 10.1067/mva.2003.115
Ouwendijk, 2008, Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial, AJR Am J Roentgenol, 190, 1349, 10.2214/AJR.07.3359
Hingorani, 2007, Preprocedural imaging: new options to reduce need for contrast angiography, Semin Vasc Surg, 20, 15, 10.1053/j.semvascsurg.2007.02.005
Met, 2009, Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis, JAMA, 301, 415, 10.1001/jama.301.4.415
Poon, 1997, Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography, AJR Am J Roentgenol, 169, 1139, 10.2214/ajr.169.4.9308478
Ho, 1998, Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography, Radiology, 206, 673, 10.1148/radiology.206.3.9494485
Quinn, 1998, Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography, Radiology, 206, 693, 10.1148/radiology.206.3.9494487
Nelemans, 2000, Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography, Radiology, 217, 105, 10.1148/radiology.217.1.r00oc11105
Koelemay, 2001, Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a metaanalysis, JAMA, 285, 1338, 10.1001/jama.285.10.1338
Barnes, 1991, Noninvasive diagnostic assessment of peripheral vascular disease, Circulation, 83, I20
Clement, 1985, Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lower limbs, Int Angiol, 4, 69
Watson, 2008, Exercise for intermittent claudication, Cochrane Database Syst Rev, CD000990
Gardner, 1995, Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis, JAMA, 274, 975, 10.1001/jama.1995.03530120067043
Bendermacher, 2006, Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication, Cochrane Database Syst Rev, CD005263
Hiatt, 1994, Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response, Circulation, 90, 1866, 10.1161/01.CIR.90.4.1866
Hodges, 2008, Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease, Clin Physiol Funct Imaging, 28, 32, 10.1111/j.1475-097X.2007.00770.x
Claeys, 1982, Study on the non-drug, conservative treatment of intermittent claudication, T Geneeskunde, 38, 585
Treat-Jacobson, 2009, Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication, Vasc Med, 14, 203, 10.1177/1358863X08101858
Pande, 2010, A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication, Vasc Med, 15, 181, 10.1177/1358863X10361545
Momsen, 2009, Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies, Eur J Vasc Endovasc Surg, 38, 463, 10.1016/j.ejvs.2009.06.002
O’Donnell, 2009, The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease, J Vasc Surg, 49, 1226, 10.1016/j.jvs.2008.11.098
Lehert, 1994, Naftidrofuryl in intermittent claudication: a retrospective analysis, J Cardiovasc Pharmacol, 23, S48, 10.1097/00005344-199400233-00010
De Backer, 2009, Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data, BMJ, 338, b603, 10.1136/bmj.b603
Spengel, 2002, Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program, Int Angiol, 21, 20
Brevetti, 1999, European multicenter study on propionyl-Lcarnitine in intermittent claudication, J Am Coll Cardiol, 34, 1618, 10.1016/S0735-1097(99)00373-3
Hiatt, 2001, Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication, Am J Med, 110, 616, 10.1016/S0002-9343(01)00704-5
Leizorovicz, 2008, Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebocontrolled, 4-year study, Circulation, 117, 816, 10.1161/CIRCULATIONAHA.107.706374
De Backer, 2008, Buflomedil for intermittent claudication, Cochrane Database Syst Rev, CD000988
De Backer, 2009, Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication, Drug Saf, 32, 283, 10.2165/00002018-200932040-00003
De Buyzere, 2008, Management of hypertension in peripheral arterial disease, Prog Cardiovasc Dis, 50, 238, 10.1016/j.pcad.2007.08.001
Shahin, 2011, Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease?. A systematic review and meta-analysis of randomised controlled trials, Int J Surg, 9, 209, 10.1016/j.ijsu.2010.12.006
Bogaert, 1983, Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication, Eur Heart J, 4, 203, 10.1093/oxfordjournals.eurheartj.a061440
Paravastu, 2009, Beta blockers for peripheral arterial disease, Eur J Vasc Endovasc Surg, 38, 66, 10.1016/j.ejvs.2009.02.019
Nicolai, 2009, Ginkgo biloba for intermittent claudication, Cochrane Database Syst Rev, 10.1002/14651858.CD006888.pub2
Labropoulos, 2002, Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review, Vasc Med, 7, 141, 10.1191/1358863x02vm423oa
De Haro, 2010, A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication, J Vasc Surg, 51, 857, 10.1016/j.jvs.2009.10.116
Diehm, 2007, A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries, Eur Heart J, 28, 798, 10.1093/eurheartj/ehl545
Spronk, 2009, Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training—randomized controlled trial, Radiology, 250, 586, 10.1148/radiol.2501080607
Klein, 2004, Long-term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: The Dutch Iliac Stent Trial Study, Radiology, 232, 491, 10.1148/radiol.2322030725
Bosch, 1997, Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease, Radiology, 204, 87, 10.1148/radiology.204.1.9205227
Kashyap, 2008, The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction, J Vasc Surg, 48, 1451, 10.1016/j.jvs.2008.07.004
Grenacher, 2006, In vitro comparison of self-expanding versus balloon-expandable stents in a human ex vivo model, Cardiovasc Intervent Radiol, 29, 249, 10.1007/s00270-004-0295-y
Tetteroo E, Van der Graaf Y, Bosch JL, Van Engelen AD, Hunink MG, Eikelboom BC, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351: 1153-9.
Schillinger, 2007, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation, 115, 2745, 10.1161/CIRCULATIONAHA.107.688341
Dick, 2009, Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions, Catheter Cardiovasc Interv, 74, 1090, 10.1002/ccd.22128
Scheinert, 2005, Prevalence and clinical impact of stent fractures after femoropopliteal stenting, J Am Coll Cardiol, 45, 312, 10.1016/j.jacc.2004.11.026
Duda, 2006, Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial, J Endovasc Ther, 13, 701, 10.1583/05-1704.1
Tepe, 2008, Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg, N Engl J Med, 358, 689, 10.1056/NEJMoa0706356
Kedora, 2007, Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral- popliteal bypass in the treatment of superficial femoral arterial occlusive disease, J Vasc Surg, 45, 10, 10.1016/j.jvs.2006.08.074
Laird, 2010, Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelvemonth results from the RESILIENT randomized trial, Circ Cardiovasc Interv, 3, 267, 10.1161/CIRCINTERVENTIONS.109.903468
Ferraresi, 2009, Longterm outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia, Eur J Vasc Endovasc Surg, 37, 336, 10.1016/j.ejvs.2008.12.001
Conrad, 2009, Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease, J Vasc Surg, 50, 799, 10.1016/j.jvs.2009.05.026
Siablis, 2009, Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome, J Vasc Interv Radiol, 20, 1141, 10.1016/j.jvir.2009.05.031
Chiu, 2010, Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease, Eur J Vasc Endovasc Surg, 39, 460, 10.1016/j.ejvs.2009.12.014
Twine, 2010, Graft type for femoro-popliteal bypass surgery, Cochrane Database Syst Rev, CD001487
Griffiths, 2004, Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting, Br J Surg, 91, 560, 10.1002/bjs.4501
SCAMICO, 2010, PTFE bypass to below-knee arteries: distal vein collar or not?. A prospective randomised multicentre study, Eur J Vasc Endovasc Surg, 39, 747, 10.1016/j.ejvs.2010.01.016
Takagi, 2010, A contemporary metaanalysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting, J Vasc Surg, 52, 232, 10.1016/j.jvs.2010.02.010
Johnson, 2000, A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal aboveknee revascularization: a prospective randomized Department of Veterans Affairs cooperative study, J Vasc Surg, 32, 268, 10.1067/mva.2000.106944
Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplastyfirst revascularization strategy, J Vasc Surg, 51, S5, 10.1016/j.jvs.2010.01.073
Adam, 2005, Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, 366, 1925, 10.1016/S0140-6736(05)67704-5
Bradbury, 2010, BASIL TrialParticipants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making, J Vasc Surg, 51, S52, 10.1016/j.jvs.2010.01.077
Diehm, 2008, TASC II section E3 on the treatment of acute limb ischemia: commentary from European interventionists, J Endovasc Ther, 15, 126, 10.1583/07-2255.1
Bandyk, 2007, Surveillance after lower extremity arterial bypass, Perspect Vasc Surg Endovasc Ther, 19, 376, 10.1177/1531003507310460
Davies, 2005, Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST), Circulation, 112, 1985, 10.1161/CIRCULATIONAHA.104.518738
Brumberg, 2007, The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure, J Vasc Surg, 46, 1160, 10.1016/j.jvs.2007.07.046
Brown, 2008, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, CD000535
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet. 2000; 355:346-51.
Johnson, 2002, Department of Veterans Affairs Cooperative Study #362. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study, J Vasc Surg, 35, 413, 10.1067/mva.2002.121847
Sarac, 1998, Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure, J Vasc Surg, 28, 446, 10.1016/S0741-5214(98)70130-2
Belch JJ, Dormandy J; CASPAR Writing Committee. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010; 52:825-33, 833.e821-2.
Dagher, 2007, Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins, Semin Vasc Surg, 20, 10, 10.1053/j.semvascsurg.2007.02.006
Tateishi-Yuyama, 2002, Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial, Lancet, 360, 427, 10.1016/S0140-6736(02)09670-8
Kusumanto, 2006, Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial, Hum Gene Ther, 17, 683, 10.1089/hum.2006.17.683
Nikol, 2008, Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia, Mol Ther, 16, 972, 10.1038/mt.2008.33
Shigematsu, 2010, Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia, Gene Ther, 17, 1152, 10.1038/gt.2010.51
Grossman, 2007, Results from a phase II multicenter, double-blind placebocontrolled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease, Am Heart J, 153, 874, 10.1016/j.ahj.2007.01.038
Huang, 2007, Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrowmononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans, Thromb Haemost, 98, 1335, 10.1160/TH07-02-0137
Sprengers, 2010, Stem cell therapy in PAD, Eur J Vasc Endovasc Surg, 39, S38, 10.1016/j.ejvs.2009.12.001
Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, et al; on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomized placebocontrolled trial of gene therapy in critical limb ischaemia. Lancet. 2011; 377:1929-37.
Whyman, 1997, Is intermittent claudication improved by percutaneous transluminal angioplasty?. A randomized controlled trial, J Vasc Surg, 26, 551, 10.1016/S0741-5214(97)70052-1
Murphy, 2008, The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods, J Vasc Surg, 47, 1356, 10.1016/j.jvs.2007.12.048
Diehm, 2006, Association of low ankle brachial index with high mortality in primary care, Eur Heart J, 27, 1743, 10.1093/eurheartj/ehl092
Slovut, 2008, Critical limb ischemia: medical and surgical management, Vasc Med, 13, 281, 10.1177/1358863X08091485
Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J Vasc Surg, 26, 517, 10.1016/S0741-5214(97)70045-4
Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007; 45:645-54.
Catalano, 2007, Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial, J Intern Med, 261, 276, 10.1111/j.1365-2796.2006.01763.x
Dick, 2007, Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome, J Vasc Surg, 45, 751, 10.1016/j.jvs.2006.12.022
Lawrence, 2010, When should open surgery be the initial option for critical limb ischaemia?, Eur J Vasc Endovasc Surg, 39, S32, 10.1016/j.ejvs.2009.11.032
Van Damme, 2003, Crural artery bypass with the autogenous greater saphenous vein, Eur J Vasc Endovasc Surg, 26, 635, 10.1016/S1078-5884(03)00345-9
Pomposelli, 2003, A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases, J Vasc Surg, 37, 307, 10.1067/mva.2003.125
Conte, 2009, Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia, J Vasc Surg, 50, 1462, 10.1016/j.jvs.2009.09.044
Wolfe, 1997, Critical and subcritical ischaemia, Eur J Vasc Endovasc Surg, 13, 578, 10.1016/S1078-5884(97)80067-6
Taylor, 2007, Critical analysis of clinical success after surgical bypass for lowerextremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment, J Am Coll Surg, 204, 831, 10.1016/j.jamcollsurg.2007.01.037
Dormandy, 1996, Prostanoid drug therapy for peripheral arterial occlusive disease— the European experience, Vasc Med, 1, 155, 10.1177/1358863X9600100212
Creutzig, 2004, Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV, Vasa, 33, 137, 10.1024/0301-1526.33.3.137
Ruffolo, 2010, Prostanoids for critical limb ischaemia, Cochrane Database Syst Rev, CD006544
Ubbink, 2005, Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia, Cochrane Database Syst Rev, CD004001
Sobel, 2008, Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, S815, 10.1378/chest.08-0686
Ouriel, 1994, A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia, J Vasc Surg, 19, 1021, 10.1016/S0741-5214(94)70214-4
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994; 220:251-66.
Ouriel, 1998, A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs, N Engl J Med, 338, 1105, 10.1056/NEJM199804163381603
Wijns, 2010, Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277
Cupples, 1993, Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study, Am Heart J, 125, 863, 10.1016/0002-8703(93)90182-9
Alberts, 2009, Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry, Eur Heart J, 30, 2318, 10.1093/eurheartj/ehp355
Ferrieres, 2006, Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting, Int J Cardiol, 112, 302, 10.1016/j.ijcard.2005.09.024
Aboyans, 2009, Indications for carotid screening in patients with coronary artery disease, Presse Med, 38, 977, 10.1016/j.lpm.2009.02.015
Blacker, 2004, The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery, Mayo Clin Proc, 79, 223, 10.4065/79.2.223
Aboyans, 2005, A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting, Interact Cardiovasc Thorac Surg, 4, 90, 10.1510/icvts.2004.092262
Brown, 2003, Multistate population-based outcomes of combined carotid endarterectomy and coronary artery bypass, J Vasc Surg, 37, 32, 10.1067/mva.2003.60
Naylor, 2003, A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: influence of surgical and patient variables, Eur J Vasc Endovasc Surg, 26, 230, 10.1053/ejvs.2002.1975
Kolh, 2006, Concurrent coronary and carotid artery surgery: factors influencing perioperative outcome and long-term results, Eur Heart J, 27, 49, 10.1093/eurheartj/ehi494
Hill, 2005, Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada, Neurology, 64, 1435, 10.1212/01.WNL.0000158477.55659.FE
Dubinsky, 2007, Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US, Neurology, 68, 195, 10.1212/01.wnl.0000250328.74755.5f
Byrne, 2006, Combined carotid endarterectomy and coronary artery bypass grafting in patients with asymptomatic high-grade stenoses: an analysis of 758 procedures, J Vasc Surg, 44, 67, 10.1016/j.jvs.2006.03.031
Char, 2002, Combined coronary artery bypass and carotid endarterectomy: long-term results, Cardiovasc Surg, 10, 111, 10.1177/096721090201000204
Cywinski, 2006, Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery, J Cardiothorac Vasc Anesth, 20, 796, 10.1053/j.jvca.2006.01.022
Ricotta, 2005, The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study, J Vasc Surg, 41, 397, 10.1016/j.jvs.2004.11.035
Timaran, 2008, Trends and outcomes of concurrent carotid revascularization and coronary bypass, J Vasc Surg, 48, 355, 10.1016/j.jvs.2008.03.031
Ziada, 2005, Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure), Am J Cardiol, 96, 519, 10.1016/j.amjcard.2005.04.012
Kovacic, 2006, Staged carotid artery stenting and coronary artery bypass graft surgery: initial results from a single center, Catheter Cardiovasc Interv, 67, 142, 10.1002/ccd.20487
Randall, 2006, Is there any benefit from staged carotid and coronary revascularization using carotid stents?. A single-center experience highlights the need for a randomized controlled trial, Stroke, 37, 435, 10.1161/01.STR.0000198876.32450.a7
Mendiz, 2006, Synchronous carotid stenting and cardiac surgery: an initial single-center experience, Catheter Cardiovasc Interv, 68, 424, 10.1002/ccd.20883
Van der Heyden, 2007, Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results, Circulation, 116, 2036, 10.1161/CIRCULATIONAHA.106.658625
Ghosh, 2005, The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing coronary artery bypass surgery, Eur J Vasc Endovasc Surg, 29, 88, 10.1016/j.ejvs.2004.07.011
Naylor, 2009, A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass, Eur J Vasc Endovasc Surg, 37, 379, 10.1016/j.ejvs.2008.12.011
Van der Heyden, 2008, Will carotid angioplasty become the preferred alternative to staged or synchronous carotid endarterectomy in patients undergoing cardiac surgery?, Eur J Vasc Endovasc Surg, 36, 379, 10.1016/j.ejvs.2008.06.001
Guzman, 2008, A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery, Stroke, 39, 361, 10.1161/STROKEAHA.107.495010
Wiesmann, 2008, Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: metaanalysis of randomized trial data, Eur Radiol, 18, 2956, 10.1007/s00330-008-1077-8
Versaci, 2009, Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study, JACC Cardiovasc Interv, 2, 393, 10.1016/j.jcin.2009.02.010
Park, 2004, The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography, Heart Vessels, 19, 275, 10.1007/s00380-004-0789-1
Zhang, 2006, Prevalence and risk factors of atherosclerotic renal artery stenosis in 1,200 Chinese patients undergoing coronary angiography, Nephron Clin Pract, 104, c185, 10.1159/000095854
Harding, 1992, Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization, J Am Soc Nephrol, 2, 1608, 10.1681/ASN.V2111608
Gross, 1997, Relation between arteriosclerosis in the coronary and renal arteries, Am J Cardiol, 80, 1478, 10.1016/S0002-9149(97)00727-3
Przewlocki, 2008, Renal artery stenosis in patients with coronary artery disease, Kardiol Pol, 66, 856
Tumelero, 2006, Prevalence of renal artery stenosis in 1,656 patients who have undergone cardiac catheterization, Arq Bras Cardiol, 87, 248
Kownator, 2009, Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study, Arch Cardiovasc Dis, 102, 625, 10.1016/j.acvd.2009.05.004
Hirsch, 2001, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, 1317, 10.1001/jama.286.11.1317
Agnelli, 2006, Polyvascular Atherothrombosis Observational Survey Investigators. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events, J Thromb Haemost, 4, 2599, 10.1111/j.1538-7836.2006.02225.x
Poredos, 2007, The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients, Angiology, 58, 309, 10.1177/0003319707302494
Hayoz, 2005, Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease, J Intern Med, 258, 238, 10.1111/j.1365-2796.2005.01536.x
Eagle, 1994, Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators, J Am Coll Cardiol, 23, 1091, 10.1016/0735-1097(94)90596-7
Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U. Short- and longterm prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med. 1994; 96:15-9.
Makowsky, 2008, Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy, Am Heart J, 155, 348, 10.1016/j.ahj.2007.09.005
Brevetti, 2004, Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy, Atherosclerosis, 175, 131, 10.1016/j.atherosclerosis.2004.03.009
Mukherjee, 2007, Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events), Am J Cardiol, 100, 1, 10.1016/j.amjcard.2007.02.046
Leger, 1999, Chronic obliterative arterial disease of the lower limbs in the coronary patient: prevalence and prognostic incidence The Monica Toulouse register, Rev Med Interne, 20, 404, 10.1016/S0248-8663(99)83091-4
Saw, 2006, The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials, J Am Coll Cardiol, 48, 1567, 10.1016/j.jacc.2006.03.067
Rihal, 1999, Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation, Circulation, 100, 171, 10.1161/01.CIR.100.2.171
Aboyans, 2005, Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting, J Am Coll Cardiol, 46, 815, 10.1016/j.jacc.2005.05.066
Monaco, 2009, Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study, J Am Coll Cardiol, 54, 989, 10.1016/j.jacc.2009.05.041
McFalls, 2004, Coronaryartery revascularization before elective major vascular surgery, N Engl J Med, 351, 2795, 10.1056/NEJMoa041905
Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, et al; DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007; 49:1763-9.
Hertzer, 1985, Coronary angiography in 506 patients with extracranial cerebrovascular disease, Arch Intern Med, 145, 849, 10.1001/archinte.1985.00360050105017
Hofmann, 2005, Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease, Heart, 91, 1438, 10.1136/hrt.2004.050906
Illuminati, 2010, Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial, Eur J Vasc Endovasc Surg, 39, 139, 10.1016/j.ejvs.2009.11.015
Hertzer, 1984, Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management, Ann Surg, 199, 223, 10.1097/00000658-198402000-00016
Bhatt, 2006, International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis, JAMA, 295, 180, 10.1001/jama.295.2.180
Aronow, 1994, Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women >or=62 years of age, Am J Cardiol, 74, 64, 10.1016/0002-9149(94)90493-6
Ness, 1999, Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice, J Am Geriatr Soc, 47, 1255, 10.1111/j.1532-5415.1999.tb05208.x
Lange, 2005, Excess 1-year cardiovascular risk in elderly primary care patients with a low anklebrachial index (ABI) and high homocysteine level, Atherosclerosis, 178, 351, 10.1016/j.atherosclerosis.2004.09.003
Bhatt, 2010, Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis, JAMA, 304, 1350, 10.1001/jama.2010.1322